Cargando…

The Complexity of Antibody Responses Elicited against the Respiratory Syncytial Virus Glycoproteins in Hospitalized Children Younger than 2 Years

The influence of age and maternal antibodies on the antibody responses to human respiratory syncytial virus (hRSV) glycoproteins in very young children has been a matter of controversy. Both, immaturity of the immune system at very early age and suppression of the host immune response by high level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trento, Alfonsina, Rodríguez-Fernández, Rosa, González-Sánchez, María I., González-Martínez, Felipe, Mas, Vicente, Vázquez, Mónica, Palomo, Concepción, Melero, José A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702767/ https://www.ncbi.nlm.nih.gov/pubmed/29213258 http://dx.doi.org/10.3389/fmicb.2017.02301

Ejemplares similares

Antigenic and sequence variability of the human respiratory syncytial virus F glycoprotein compared to related viruses in a comprehensive dataset
por: Mas, Vicente, et al.
Publicado: (2018)

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
por: Detalle, Laurent, et al.
Publicado: (2015)

Generation of monoclonal antibodies specific of the postfusion conformation of the Pneumovirinae fusion (F) protein
por: Rodríguez, Laura, et al.
Publicado: (2015)

The Burden of Severe Respiratory Syncytial Virus Disease Among Children Younger than 1 Year in Central and Eastern Europe
por: Van de Steen, Olivier, et al.
Publicado: (2016)

Antibody Responses to Respiratory Syncytial Virus: A Cross-Sectional Serosurveillance Study in the Dutch Population Focusing on Infants Younger Than 2 Years
por: Berbers, Guy, et al.
Publicado: (2020)

Palivizumab prophylaxis against respiratory syncytial virus infection in patients younger than 2 years of age with congenital heart disease
por: Mohammed, Mohammed Hassan A., et al.
Publicado: (2021)

Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein
por: Battles, Michael B., et al.
Publicado: (2017)

Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
por: Rossey, Iebe, et al.
Publicado: (2017)

Role of oligosaccharides in the structure and function of respiratory syncytial virus glycoproteins
por: Lambert, Dennis M.
Publicado: (1988)

Interactions of heparin with key glycoproteins of human respiratory syncytial virus
por: Shi, Deling, et al.
Publicado: (2023)

Features of the Human Antibody Response against the Respiratory Syncytial Virus Surface Glycoprotein G
por: Borochova, Kristina, et al.
Publicado: (2020)

Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
por: Rossey, Iebe, et al.
Publicado: (2017)

Epidemiology and risk factors of respiratory syncytial virus associated acute respiratory tract infection in hospitalized children younger than 5 years from Sri Lanka
por: Divarathna, Maduja V. M., et al.
Publicado: (2023)

Age and respiratory syncytial virus etiology in bronchiolitis clinical outcomes
por: Rodriguez-Fernandez, Rosa, et al.
Publicado: (2022)

Helical ordering of envelope‐associated proteins and glycoproteins in respiratory syncytial virus
por: Conley, Michaela J, et al.
Publicado: (2021)

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
por: Tian, Daiyin, et al.
Publicado: (2017)

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein
por: Gilman, Morgan S. A., et al.
Publicado: (2015)

A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year( )
por: Suh, Mina, et al.
Publicado: (2022)

Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update
por: Vázquez, Yaneisi, et al.
Publicado: (2019)

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
por: Li, You, et al.
Publicado: (2022)

Requirements for Human Respiratory Syncytial Virus Glycoproteins in Assembly and Egress from Infected Cells
por: Batonick, Melissa, et al.
Publicado: (2011)

Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus
por: Boyington, Jeffrey C., et al.
Publicado: (2016)

Iterative structure-based improvement of a respiratory syncytial virus fusion glycoprotein vaccine
por: Joyce, M. Gordon, et al.
Publicado: (2016)

Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein
por: Flynn, Jessica A., et al.
Publicado: (2016)

Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level
por: Salimi, Vahid, et al.
Publicado: (2021)

Intranasal immunization with a helper-dependent adenoviral vector expressing the codon-optimized fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in BALB/c mice
por: Fu, Yuan-Hui, et al.
Publicado: (2013)

Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases
por: Lee, Hyo-Jeong, et al.
Publicado: (2017)

Dual Role of Respiratory Syncytial Virus Glycoprotein Fragment as a Mucosal Immunogen and Chemotactic Adjuvant
por: Kim, Sol, et al.
Publicado: (2012)

Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus
por: Sastry, Mallika, et al.
Publicado: (2017)

Ephedrae Herba and Cinnamomi Cortex interactions with G glycoprotein inhibit respiratory syncytial virus infectivity
por: Fujikane, Aya, et al.
Publicado: (2022)

Roflumilast Inhibits Respiratory Syncytial Virus Infection in Human Differentiated Bronchial Epithelial Cells
por: Mata, Manuel, et al.
Publicado: (2013)

Metabolic changes during respiratory syncytial virus infection of epithelial cells
por: Martín-Vicente, María, et al.
Publicado: (2020)

Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study
por: Bardsley, Megan, et al.
Publicado: (2023)

Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein
por: Cimica, Velasco, et al.
Publicado: (2016)

A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus
por: Stewart-Jones, Guillaume B. E., et al.
Publicado: (2015)

Are saltmarshes younger than mangrove swamps?
por: Vermeij, Geerat J.
Publicado: (2022)

Recombinant Soluble Respiratory Syncytial Virus F Protein That Lacks Heptad Repeat B, Contains a GCN4 Trimerization Motif and Is Not Cleaved Displays Prefusion-Like Characteristics
por: Widjaja, Ivy, et al.
Publicado: (2015)

Respiratory Syncytial Virus Coinfections With Rhinovirus and Human Bocavirus in Hospitalized Children
por: Calvo, Cristina, et al.
Publicado: (2015)

Development of Luciferase Immunoprecipitation Systems (LIPS) Assay to Detect IgG Antibodies against Human Respiratory Syncytial Virus G-Glycoprotein
por: Crim, Roberta Lynne, et al.
Publicado: (2019)

Virus-Like Particles Assembled Using Respiratory Syncytial Virus Matrix Protein Elicit Protective Immunity in Mice
por: Lee, Su-Hwa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jdci239hm75vfp4h5aoq3rkf20